Showing results (251-260 of 436) with videos related to
Sort By:
Pageof 44
European Journal of Haematology|February 5, 2009
High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosisAnne-Tove Brenne, Unn-Merete Fagerli, John D Shaughnessy, et al.Blood Advances|January 29, 2020
Long-term outcomes after autologous stem cell transplantation for multiple myelomaKatherine K Nishimura, Bart Barlogie, Frits van Rhee, et al.Oncogene|July 27, 2005
ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myelomaAtsushi Suzuki, Shinsuke Iida, Miyuki Kato-Uranishi, et al.BJOG : an International Journal of Obstetrics and Gynaecology|May 14, 2003
Antenatal screening for human platelet antigen-1a: results of a prospective study at a large maternity hospital in IrelandAnne Davoren, Peter McParland, John Crowley, et al.Frontiers in Pediatrics|July 22, 2022
Association Between Language Use and ICU Transfer and Serious Adverse Events in Hospitalized Pediatric Patients Who Experience Rapid Response ActivationJessica E McDade, Aleksandra E Olszewski, Pingping Qu, et al.Journal of Pediatric Nursing|August 10, 2021
Mental health comorbidities in adolescents and young adults with type 2 diabetesAlissa J Roberts, Hao Bao, Pingping Qu, et al.British Journal of Haematology|September 22, 2005
Response to bortezomib is associated to osteoblastic activation in patients with multiple myelomaMaurizio Zangari, Dixie Esseltine, Choon-Kee Lee, et al.Cancer Nursing|April 28, 2011
Fatigue, sleep, pain, mood, and performance status in patients with multiple myelomaElizabeth Ann Coleman, Julia A Goodwin, Sharon K Coon, et al.Clinical Case Reports|April 4, 2015
Fulminant onset of acute leukemia from normal hematopoiesis within 3 months of follow up for multiple myeloma treated with total therapy protocolsZeba N Singh, Yogesh Jethava, Ginell R Post, et al.Immunotherapy|February 19, 2016
Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?Sharmilan Thanendrarajan, Faith E Davies, Gareth J Morgan, et al.Pageof 44